Structural basis of transcription inhibition by fidaxomicin (lipiarmycin A3)
Fidaxomicin is an antibacterial drug in clinical use for treatment of Clostridium difficile diarrhea. The active ingredient of fidaxomicin, lipiarmycin A3 (Lpm), functions by inhibiting bacterial RNA polymerase (RNAP). Here we report a cryo-EM structure of Mycobacterium tuberculosis RNAP holoenzyme...
Huvudupphovsmän: | Lin, W, Das, K, Degen, D, Mazumder, A, Duchi, D, Wang, D, Ebright, Y, Ebright, R, Sineva, E, Gigliotti, M, Srivastava, A, Mandal, S, Jiang, Y, Liu, Y, Yin, R, Zhang, Z, Eng, E, Thomas, D, Donadio, S, Zhang, H, Zhang, C, Kapanidis, A |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Cell Press
2018
|
Liknande verk
Liknande verk
-
Site-specific incorporation of fluorescent probes into protein: hexahistidine-tag-mediated fluorescent labeling with (Ni(2+):nitrilotriacetic Acid (n)-fluorochrome conjugates.
av: Kapanidis, A, et al.
Publicerad: (2001) -
The RNA polymerase clamp interconverts dynamically among three states and is stabilized in a partly closed state by ppGpp
av: Duchi, D, et al.
Publicerad: (2018) -
Mean DNA bend angle and distribution of DNA bend angles in the CAP-DNA complex in solution.
av: Kapanidis, A, et al.
Publicerad: (2001) -
Fluorescence resonance energy transfer (FRET) in analysis of transcription-complex structure and function.
av: Mukhopadhyay, J, et al.
Publicerad: (2003) -
Translocation of sigma(70) with RNA polymerase during transcription: fluorescence resonance energy transfer assay for movement relative to DNA.
av: Mukhopadhyay, J, et al.
Publicerad: (2001)